CHRISTOPHER JONES: Open Payments
NPI 1639162092 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,621 in 68 payments from 15 companies in 2025. Trend: 2023 $1,903 · 2024 $1,288 · 2025 $1,621
Food & beverage: $1,621
| Company | Payments | Amount |
|---|---|---|
| SCPHARMACEUTICALS INC. | 16 | $377 |
| Novartis Pharmaceuticals Corporation | 12 | $257 |
| Merck Sharp & Dohme LLC | 9 | $239 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $196 |
| Alnylam Pharmaceuticals Inc. | 4 | $118 |
| Amgen Inc. | 4 | $94 |
| BridgeBio Pharma, Inc. | 2 | $71 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $71 |
| Abbott Laboratories | 2 | $41 |
| Cleerly, Inc. | 1 | $34 |
Products named: FUROSCIX, LEQVIO, JARDIANCE, VERQUVO, ONPATTRO, REPATHA, Attruby, Kerendia.
Industry payments across FL — which companies pay providers there.
